Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases (Event Video)
11/2/11
An estimated one billion people suffer from one or more neglected diseases like Tuberculosis, Malaria, Dengue Fever or others, and hundreds of millions of dollars have been spent to find effective treatments. Medicines, therapies and treatments have been discovered, but regulatory barriers in the late-stage clinical trials of developing countries have prevented these drugs from helping those in need.
Ten years after President Clinton's initiative to avert a global epidemic of tobacco-related disease, smoking is down in the United States but rising fast in poor countries, where Washington turns a blind eye to aggressive cigarette marketing banned at home.